Additionally, clinical studies focusing on the efficacy of tailored treatments based on specific EGFR mutation profiles, as highlighted in our research, can provide valuable insights into personalized medicine approaches for NSCLC patients. Here, EGFR is linked to non-small cell lung carcinoma.